SCHEMBL7143475

SCHEMBL7143475

CC(C)(C)OC(=O)Nc1cc(OCCOC2CCCCO2)c(I)cc1[N+](=O)[O-]

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.35
MEN1 O00255 2/20 0.35
CREBBP Q92793 1/20 0.35
HCAR3 P49019 1/20 0.35
ALDH1A1 P00352 5/20 0.34
MAPT P10636 4/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
KDM4E B2RXH2 1/20 0.32
POLB P06746 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7140551 0.85 HCAR3 (0.36) KMT2AMEN1CREBBPHCAR3ALDH1A1
SCHEMBL7147347 0.84 MAPT (0.36) KMT2AMEN1HCAR3ALDH1A1MAPT
SCHEMBL7145353 0.84 HCAR3 (0.33) KMT2AMEN1CREBBPHCAR3ALDH1A1
SCHEMBL7139782 0.83 MEN1 (0.36) KMT2AMEN1CREBBPHCAR3ALDH1A1
SCHEMBL7147448 0.82 NPC1 (0.39) KMT2AMEN1ALDH1A1MAPTNPC1
SCHEMBL7141800 0.82 NPC1 (0.41) KMT2AHCAR3ALDH1A1MAPTNPC1
SCHEMBL7141773 0.80 ALDH1A1 (0.42) KMT2AMEN1ALDH1A1MAPTNPC1
SCHEMBL7143075 0.78 MAPT (0.35) KMT2AMEN1HCAR3ALDH1A1MAPT
SCHEMBL7698485 0.77 MEN1 (0.40) KMT2AMEN1ALDH1A1MAPTNPC1
SCHEMBL7144299 0.77 TDP1 (0.40) ALDH1A1NPC1RAB9ACYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed